logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Ideaya Biosciences, Inc.

Calculating rank
USPTO Granted Patents = 15


Trademarks = 1

Forward Citations = 6

Loading Chart...
Loading Chart...

53 inventors (with patents filed for the assignee):

goldMedal Muzaffar Alam (8 out of 9 patents)

silverMedal Hilary Plake Beck (8 out of 8 patents)

bronzeMedal Michael Patrick Dillon (7 out of 61 patents)

4.  Marcos Gonzalez-Lopez (6 out of 6 patents)

5.  James Clifford Sutton, Jr (6 out of 6 patents)

6.  Melissa Fleury (6 out of 7 patents)

7.  Zhonghua Pei (5 out of 34 patents)

8.  Leah Cleary (4 out of 5 patents)

9.  John E Knox (4 out of 5 patents)

10.  Richard Steel (3 out of 4 patents)

11.  Zachary E R Newby (3 out of 4 patents)

12.  Paul A Barsanti (3 out of 3 patents)

13.  Brian Jones (2 out of 15 patents)

14.  Kevin J Duffy (2 out of 32 patents)

15.  James A Sutton (2 out of 13 patents)


15 patents:

1. 12766150 - Substituted thiadiazolyl derivatives as DNA polymerase theta inhibitors (2026-10-20),
2. 12662451 - CHEMICAL COMPOUNDS AND USES THEREOF (2026-06-23),
3. 12509454 - Thiadiazolyl derivatives (2025-12-30),
4. 12503467 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2025-12-23),
5. 12398131 - Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof (2025-08-26),
6. 12269820 - Piperazine substituted indazole compounds as inhibitors of PARG (2025-04-08),
7. 12258354 - AhR modulators (2025-03-25),
8. 12115163 - Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor (2024-10-15),
9. 11584755 - Dihydrothieno[3,2-b]pyridine compounds (2023-02-21),
10. 11548867 - Amido compounds as AhR modulators (2023-01-10),
11. 11530220 - Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhR (2022-12-20),
12. 11407764 - AhR modulators (2022-08-09),
13. 11084798 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2021-08-10),
14. 11046691 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors (2021-06-29),
15. 10815250 - AhR modulators (2020-10-27),
Company Overview
Ideaya Biosciences, Inc. is a biotechnology company based in South San Francisco, California, focused on the development of targeted therapeutics for cancer. The company specializes in precision medicine, leveraging its expertise in genomics and molecular biology to identify and validate novel drug targets. Ideaya is dedicated to advancing innovative treatment options that address unmet medical needs, with a strong emphasis on scientific rigor and collaboration within the oncology research community.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

15 Patents

#81 in South San Francisco, CA

#5,045 in California

#21,100 in US

#40,018 in the World

South San Francisco, CA (US)
South San Francisco, CA, United States of America

Ideaya Biosciences, Inc.

Forward Citations = 6

53 inventors:

goldMedal Muzaffar Alam (8 out of 9 patents)

silverMedal Hilary Plake Beck (8 out of 8 patents)

bronzeMedal Michael Patrick Dillon (7 out of 61 patents)

4.  Marcos Gonzalez-Lopez (6 out of 6 patents)

5.  James Clifford Sutton, Jr (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ideaya Biosciences, Inc.. Retrieved from https://idiyas.com/company/ideaya-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…